1. Home
  2. PCVX vs SEIC Comparison

PCVX vs SEIC Comparison

Compare PCVX & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • SEIC
  • Stock Information
  • Founded
  • PCVX 2013
  • SEIC 1968
  • Country
  • PCVX United States
  • SEIC United States
  • Employees
  • PCVX N/A
  • SEIC N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • SEIC Investment Bankers/Brokers/Service
  • Sector
  • PCVX Health Care
  • SEIC Finance
  • Exchange
  • PCVX Nasdaq
  • SEIC Nasdaq
  • Market Cap
  • PCVX 4.4B
  • SEIC 9.7B
  • IPO Year
  • PCVX 2020
  • SEIC N/A
  • Fundamental
  • Price
  • PCVX $33.27
  • SEIC $91.96
  • Analyst Decision
  • PCVX Strong Buy
  • SEIC Buy
  • Analyst Count
  • PCVX 10
  • SEIC 5
  • Target Price
  • PCVX $136.50
  • SEIC $95.40
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • SEIC 954.5K
  • Earning Date
  • PCVX 08-05-2025
  • SEIC 07-23-2025
  • Dividend Yield
  • PCVX N/A
  • SEIC 1.07%
  • EPS Growth
  • PCVX N/A
  • SEIC 25.40
  • EPS
  • PCVX N/A
  • SEIC 4.59
  • Revenue
  • PCVX N/A
  • SEIC $2,164,916,000.00
  • Revenue This Year
  • PCVX N/A
  • SEIC $6.30
  • Revenue Next Year
  • PCVX N/A
  • SEIC $4.52
  • P/E Ratio
  • PCVX N/A
  • SEIC $20.02
  • Revenue Growth
  • PCVX N/A
  • SEIC 10.33
  • 52 Week Low
  • PCVX $27.66
  • SEIC $62.38
  • 52 Week High
  • PCVX $121.06
  • SEIC $93.75
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 46.99
  • SEIC 76.73
  • Support Level
  • PCVX $32.00
  • SEIC $82.79
  • Resistance Level
  • PCVX $34.63
  • SEIC $93.75
  • Average True Range (ATR)
  • PCVX 1.31
  • SEIC 1.56
  • MACD
  • PCVX -0.08
  • SEIC 0.67
  • Stochastic Oscillator
  • PCVX 37.46
  • SEIC 84.19

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About SEIC SEI Investments Company

SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $87 billion in assets under management. As of December 2024, SEI (including LSV) manages, administers, or advises about $1.6 trillion in assets.

Share on Social Networks: